Overview
Time-Effect of Montelukast Protection
Status:
Completed
Completed
Trial end date:
2008-08-01
2008-08-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The aim of this study is to verify MNT time of onset of protection against EIB in asthmatic children by evaluating different time intervals between dosing and challenge, after a single-dose and after three days of once a day MNT administration.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Universita di VeronaTreatments:
Montelukast
Criteria
Inclusion Criteria:- children with exercise-induced asthma
Exclusion Criteria:
- viral infections
- montelukast treatment